(Q54561449)

31 May 2018

title

TNF-dependent overexpression of CCL21 is an underlying cause of progressive lymphoaccumulation in generalized lymphoproliferative disorder. (English)

1 reference

31 May 2018

0 references

1 reference

5

1 reference

31 May 2018

author name string

Florian Wiede

1

1 reference

31 May 2018

Karen Vana

2

1 reference

31 May 2018

Lisa M Sedger

3

1 reference

31 May 2018

Anja Lechner

4

1 reference

31 May 2018

language of work or name

English

0 references

publication date

1 February 2007

1 reference

31 May 2018

European Journal of Immunology

published in

1 reference

31 May 2018

volume

37

1 reference

31 May 2018

issue

2

1 reference

31 May 2018

page(s)

351-357

1 reference

31 May 2018

Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636218

7 January 2021

The lpr and gld genes in systemic autoimmunity: life and death in the Fas lane

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636218

7 January 2021

Induction of apoptosis in mature T cells by tumour necrosis factor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636218

7 January 2021

Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636218

7 January 2021

Tumor necrosis factor sustains the generalized lymphoproliferative disorder (gld) phenotype

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636218

7 January 2021

Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636218

7 January 2021

Characterization of the in vivo function of TNF-alpha-related apoptosis-inducing ligand, TRAIL/Apo2L, using TRAIL/Apo2L gene-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636218

7 January 2021

In vivo-activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636218

7 January 2021

Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636218

7 January 2021

Transgenic overexpression of the CC chemokine CCL21 disrupts T-cell migration

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636218

7 January 2021

The role of chemokines in the microenvironmental control of T versus B cell arrest in Peyer's patch high endothelial venules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636218

7 January 2021

The lymphoid chemokine CCL21 costimulates naive T cell expansion and Th1 polarization of non-regulatory CD4+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636218

7 January 2021

A ligand for the chemokine receptor CCR7 can influence the homeostatic proliferation of CD4 T cells and progression of autoimmunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636218

7 January 2021

Distinct roles for lymphotoxin-alpha and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636218

7 January 2021

Analysis of the CCR7 expression on murine bone marrow-derived and spleen dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636218

7 January 2021

Identifiers

DOI

10.1002/EJI.200636218

1 reference

31 May 2018

1 reference

31 May 2018